2785-5309

Bleeding Thrombosis and Vascular Biology

PAGEPress Publications

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 326 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact326 DOIs
2

Deposit reference lists for 78 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact78 DOIs
3

Add abstracts to 4 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact4 DOIs

DOIs for this ISSN

Showing the top 5 of 434 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Gene transfer in hemophilia A: not cogent yet (10.4081/btvb.2022.32)
ORCID
19.45 5
2 The amazing genetic complexity of anucleated platelets (10.4081/btvb.2022.33)
ORCID
17.47 4
3 Are platelets more than a model of brain neurons? (10.4081/btvb.2022.29)
ORCID
15.05 3
4 Moving beyond p-value (10.4081/btvb.2022.30)
ORCID
15.05 3
5 Science in Ukraine is “bleeding” (10.4081/btvb.2023.69)
ORCID
15.05 3
6 Palestinian patients associations appeal on World Hemophilia… (10.4081/btvb.2024.136)
References ORCID
15.05 1
7 A case of thrombotic thrombocytopenic purpura presented in a… (10.4081/btvb.2025.181)
ORCID
15.05 3
8 In memoriam of Professor Gualtiero Palareti (1943-2025) (10.4081/btvb.2025.371)
Abstract ORCID
15.05 1
9 The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus… (10.4081/btvb.2022.11)
ORCID
11.93 2
10 Milvexian and other drugs targeting Factor XI: a new era of… (10.4081/btvb.2022.22)
ORCID
11.93 2
11 Direct oral anticoagulants: does one dose fit all? Why, when… (10.4081/btvb.2026.418)
ORCID
11.93 2
12 In memoriam of  Professor Gian Franco Gensini (1945-2026) (10.4081/btvb.2026.568)
ORCID
11.93 2
13 27<sup>th</sup> SISET National Congress | Perugi… (10.4081/btvb.2022.57)
ORCID
7.53 1
14 Safety and efficacy of treatment with vitamin K antagonists… (10.4081/btvb.2022.9)
ORCID
7.53 1
15 The metaphor of Ukrainian science "bleeding" (10.4081/btvb.2023.73)
ORCID
7.53 1
16 Risk of recurrent venous thromboembolism in cancer patients… (10.4081/btvb.2024.124)
ORCID
7.53 1
17 The importance of rigorous and engaging scientific communica… (10.4081/btvb.2025.191)
Abstract
7.53 1
18 CO15 | Longitudinal coagulation profiling of individuals un… (10.4081/btvb.2025.219)
ORCID
7.53 1
19 Medicine at the crossroads of science, compassion and ethica… (10.4081/btvb.2025.423)
ORCID
7.53 1
20 Gene therapy for hemophilia B (10.4081/btvb.2025.425)
ORCID
7.53 1
21 Thrombophilia work-up and clinical outcomes in Indian patien… (10.4081/btvb.2026.193)
ORCID
7.53 1
22 Cardiovascular risk in hormone replacement therapy (10.4081/btvb.2026.411)
ORCID
7.53 1
23 Cardiovascular risk profile evolution over 15 years: compari… (10.4081/btvb.2026.416)
ORCID
7.53 1
24 Launch of a National Registry for Congenital Hematological D… (10.4081/btvb.2026.417)
ORCID
7.53 1
25 Development of a shared decision-making tool for gene therap… (10.4081/btvb.2026.426)
ORCID
7.53 1
26 Neurovascular protective effects of nutritional intervention… (10.4081/btvb.2026.436)
ORCID
7.53 1
27 Bleeding in cancer: epidemiological aspects (10.4081/btvb.2026.453)
ORCID
7.53 1
28 Bleeding complications of oral anticoagulant therapy: from I… (10.4081/btvb.2026.457)
ORCID
7.53 1
29 Comments on “Low-dose aspirin for preventing intrauterine gr… (10.4081/btvb.2026.463)
ORCID
7.53 1
30 A lifetime in biomedical research: an interview with Silvio… (10.4081/btvb.2026.466)
ORCID
7.53 1
31 Availability of direct oral anticoagulants testing among Ita… (10.4081/btvb.2026.485)
ORCID
7.53 1
32 Why medical fiction privileges certain disease manifestation… (10.4081/btvb.2026.562)
ORCID
7.53 1
33 ERRATUM - Neurovascular protective effects of nutritional in… (10.4081/btvb.2026.569)
ORCID
7.53 1
34 Gian Franco Gensini: a memory by the Italian Society of Huma… (10.4081/btvb.2026.571)
ORCID
7.53 1
35 <i>To P or not to P. </i>That is the wrong quest… (10.4081/btvb.2026.572)
ORCID
7.53 1
36 Thrombophilia work-up and clinical outcomes in Indian patien… (10.4081/btvb..193)
ORCID
0.00 0
37 Rationale and design of a study on D-dimer use to stratify p… (10.4081/btvb.2022.10)
ORCID
0.00 0
38 Comparison among three different bleeding scores and the thr… (10.4081/btvb.2022.12)
ORCID
0.00 0
39 A nitric oxide-donor pravastatin hybrid drug exerts antiplat… (10.4081/btvb.2022.19)
ORCID
0.00 0
40 New perspectives for prevention of the post-thrombotic syndr… (10.4081/btvb.2022.20)
ORCID
0.00 0
41 An ecological alliance against air pollution and cardiovascu… (10.4081/btvb.2022.21)
ORCID
0.00 0
42 Vaccine-induced immune thrombotic thrombocytopenia following… (10.4081/btvb.2022.23)
ORCID
0.00 0
43 The night of randomized clinical trials where all patients a… (10.4081/btvb.2022.24)
ORCID
0.00 0
44 Iatrogenic pseudoaneurysm of inferior epigastric artery: not… (10.4081/btvb.2022.25)
ORCID
0.00 0
45 Treatment of venous thromboembolism in pregnancy: findings f… (10.4081/btvb.2022.28)
ORCID
0.00 0
46 Is transient ischemic attack a minor stroke? (10.4081/btvb.2022.31)
ORCID
0.00 0
47 Major bleedings in mechanical prosthetic heart valves patien… (10.4081/btvb.2022.34)
ORCID
0.00 0
48 Circulating albumin-to-fibrinogen ratio may be a risk indica… (10.4081/btvb.2022.36)
ORCID
0.00 0
49 Evaluation of Coaguchek<sup>® </sup>Pro II coagu… (10.4081/btvb.2022.37)
0.00 1
50 Clonal hematopoiesis and inflammation: a link with thrombosi… (10.4081/btvb.2022.38)
ORCID
0.00 0